Biotech Breakthroughs in Ocular Drug Delivery Aim to Replace Traditional Eye Drops with Sustained Release

Innovative ocular inserts, drug-loaded contact lenses, and microneedles are replacing traditional eye drops to provide sustained, high-efficacy eye treatments.

By: AXL Media

Published: Apr 3, 2026, 10:58 AM EDT

Source: Information for this report was sourced from Compuscript Ltd

Overcoming the Physiological Barriers of the Eye

Traditional ocular treatments, most notably liquid eye drops, have long been hindered by the eye’s natural defense mechanisms, which often lead to rapid drainage and poor absorption of active ingredients. To combat these limitations, a new generation of ocular inserts has been developed using advanced biocompatible materials such as hydrogels and biodegradable nanoparticles. These systems are designed to improve the retention time of medicine on the outer surface of the eye, ensuring that pharmaceutical ingredients can more effectively penetrate the corneal barrier.

The Evolution of Drug-Loaded Contact Lenses

Innovations in contact lens technology are transforming these common vision-correction tools into sophisticated delivery platforms. By integrating medication directly into the lens material, scientists have created a system that provides a controlled, continuous release of drugs to the ocular surface. This method significantly enhances therapeutic efficacy by maintaining a steady concentration of the drug over an extended period, eliminating the "peak and valley" effect associated with the intermittent application of traditional drops.

Microneedle Technology for Precise Intraocular Delivery

One of the most significant advancements highlighted in the research is the development of microneedle-based delivery systems. These ultra-thin, biodegradable, or open-hollow needles allow for minimally invasive penetration of the sclera or cornea. This approach bypasses external barriers to provide high bioavailability directly to the targeted tissues. Because these microneedles are designed to be minimally invasive, they offer a pathway for long-acting therapies that do not sacrifice patient comfort for accuracy.